| Study | Drug | Cycles prior to DITP | Platelet count (per μL) | Time to platelet recovery (days) | Treatment | Initial | Nadir |
| Akdeniz et al. [17] | Oxaliplatin | 12 | 151,000 | 20,000 | 6 | Corticosteroids, platelets, IVIG | Bautista et al. [6] | Oxaliplatin | 3 | 226,000 | 4,000 | 12 | Antihistamine, corticosteroids, platelets | Oxaliplatin | 3 | 87,000 | 66,000 | 14 | Corticosteroids | Buti et al. [18] | Oxaliplatin | 11 | 117,000 | 17,000 | NA | NA | Cobo et al. [19] | Oxaliplatin | 12 | 202,000 | 7,000 | NA | NA | Curtis et al. [8] | Oxaliplatin | 17 | 150,000 | 6,000 | 7 | Platelets | Oxaliplatin | 10 | 136,000 | 6,000 | 21 | Observation | Curtis et al. [10] | Oxaliplatin, irinotecan | 20 | 130,000 | 0 | NA | Corticosteroids | Oxaliplatin, irinotecan, leucovorin, dexamethasone, diphenhydramine, palonosetron | 18 | 157,000 | 5,000 | NA | Platelets | Earle et al. [20] | Oxaliplatin | 1 | 99,000 | 6,000 | 14 | Platelets, corticosteroids | Fontão-Wendel et al. [9] | Oxaliplatin | 7 | 164,000 | 5,000 | 3 | Corticosteroids, IVIG | James et al. [14] | Oxaliplatin | 28 | 145,000 | 0 | 5 | Corticosteroids, platelets | Koutras et al. [21] | Oxaliplatin | 14 | NA | NA | 2 | Corticosteroids, antihistamines, platelets | Mirtsching et al. [11] | Irinotecan | NA | 347,000 | 84-100,000 | NA | Observation | Mittal et al. [12] | Oxaliplatin | 8 | 175,000 | 4,000 | 9 | Platelets, corticosteroids | Ohta et al. [22] | Oxaliplatin | 12 | 136,000 | 35,000 | 7 | Corticosteroids | Pavic et al. [23] | Oxaliplatin | 1 | 253,000 | 5,000 | NA | Corticosteroids | Saif et al. [24] | Oxaliplatin | 11 | 89,000 | 17,000 | 2 | Platelets | Santodirocco et al. [25] | Oxaliplatin | 15 | 124,000 | 21,000 | 5 | Corticosteroids, platelets | Schade et al. [26] | Oxaliplatin | 14 | 89,000 | 5,000 | 45 | Platelets | Shao et al. [27] | Oxaliplatin | 24 | 163,000 | 4,000 | NA | Platelets | Suh et al. [15] | Oxaliplatin | 11 | 113,000 | 3,000 | 60 | Platelets, IVIG, corticosteroids | Suzuki et al. [28] | Oxaliplatin | 23 | 253,000 | 3,000 | 5 | Platelets, corticosteroids | Taleghani et al. [29] | Oxaliplatin | 15 | 221,000 | 5,000 | 5 | Platelets, corticosteroids | Tam et al. [this report] | Oxaliplatin, irinotecan | 14 | 102,000 | 8,000 | 5 | Corticosteroids, platelets | Curtis et al. [30] | Leucovorin, palonosetron | 19 | 144 | 17 | 4 | Dexamethasone | Pan et al. [31] | Oxaliplatin | 28 | NA | <5,000 | 4 | IVIG, dexamethasone |
|
|